Ethanolamine
glycerophospholipids
Analogous structures to those described for choline phospholipids exist for the
ethanolamine phospholipids. The pattern of fatty acid distribution generally shows a
higher degree of unsaturation than that found in choline phospholipids.
The diacyl derivative (1,2-diacyl-sn-glycero-3-phosphorylethanolamine,
phosphatidylethanolamine) was originally named "cephalin". This phospholipid is
a zwitterion over the pH range of 2-7 and is in the anionic form in the range 7-10.
In
mammalian and plant tissues this component usually occurs in lesser amounts than
phosphatidylcholine. In bacteria, it is the principal phospholipid present.
After the discovery of 2-aminoethylphosphonic
acid in lipid extracts of the sea anemone (Kittredge JS et al., Biochemistry
1962, 1, 624), unusual phosphatidylethanolamine analogues containing a
carbon-phosphorus bond instead of the classical carbon-oxygen-phosphorus bond
have been described in marine invertebrates and protozoa (Tetrahymena
pyriformis). They were first reported in 1966 in Tetrahymena as
glycerophosphonolipids (Liang CR et al., Biochim Biophys Acta 1966, 125, 548)
but, later, they were identified in that species as derivative of chimyl alcohol
(Thomson GA, Biochemistry 1967, 6, 2015) : an alcohol is linked with an
ether bond in sn-1 of the glycerol molecule. These phosphonolipids,
often termed phosphonylethanolamine, are extremely resistant to acid or
enzymatic hydrolysis. They were proposed as a possible artificial pulmonary
surfactant.
The alk-1'-enyl, acyl derivative (ethanolamine plasmalogen) occurs widely in nature, mainly present in
high concentration in the white matter (myelin) of the nervous system, in the heart and
the kidney. It is practically absent in plants and bacteria (except in obligate
anaerobes).
The
fatty acid acylated at the 2-position of glycerol is most frequently polyunsaturated
(arachidonic or docosahexaenoic acid). The function of ethanolamine plasmalogen remains
obscure, hypotheses concerning their role in arachidonic acid reservoir and protection of
other lipids against oxidation (through their vinyl group) were suggested (Leray
C et al. Lipids 2002, 37, 285). A function in the mediation of cellular
cholesterol efflux has been also discovered (Mandel
H et al., Biochem Biophys Res Comm 1998, 250, 369). The plasmalogen
synthesis via the peroxisomal pathway was shown to decrease with age and more
severely in patients suffering Alzheimer disease. A precise link between
plasmalogen levels and that pathology remains to be defined.
For an extensive review on functions and biosynthesis of plasmalogens in health
and disease, refer to the paper by Brites P et al. (Brites
P et al., Biochim Biophys Acta 2004, 1636, 219).
A graphical chart of the metabolism of plasmalogens may be found on the BioCarta
web site
The alkyl-, acyl-derivative (1-alkyl-, 2-acyl-sn-glycero-3-phosphorylethanolamine) is
present in small amount in all phospholipid extracts.
It
was first isolated from bovine erythrocytes but is present also in reasonably amount in
bone marrow, platelets, certain protozoa and molluscs.
N-methyl and N,N-dimethyl phosphatidylethanolamine
These groups have either N-methylethanolamine or N,N-dimethylethanolamine substituted for
ethanolamine in their structure. Bremer (Biochim Biophys Acta 1959, 35, 287) proposed a
possible role of these compounds in interconversions from phosphatidylethanolamine to
phosphatidylcholine in rat liver. This was confirmed later and extensively studied in
nervous tissues.
N-Methyl phosphatidylethanolamine has been detected in a Gram-positive bacteria Clostridium
acetobutylicum (Lepage C et al., J Gen Microbiol 1987, 133, 103).
Phosphatidylethanolamine-hydroxy-alkenals
Phosphatidylethanolamine can be covalently modified in vitro and in cellular
systems by hydroxy-alkenals, such as 4-hydroxy-2-nonenal (4-HNE; from n-6 fatty
acids), 4-hydroxy-2-hexenal (4-HHE; from n-3 fatty acids), and
4-hydroxy-dodecadienal (4-HDDE; from the 12-lipoxygenase product of arachidonic
acid), to form PE-alkenal Michael adducts (Guichardant
M et al., Free Rad Biol Med 1998, 25, 1049; Bacot
S et al., J
Lipid Res 2007, 48, 816). Below, the adduct formed between PE and
4-HHE is shown.

Several experimental results suggest that these adducts could be used as specific
markers of membrane disorders occurring in pathophysiological states with
associated oxidative stress and might affect cell function.
N-acetyl phosphatidylethanolamine
That unusual phosphatidylethanolamine derivative was described in a filamentous
fungus, Absidia corymbifera, and formed about 6% of total membrane lipids
(Batrakov
SG et al., Biochim Biophys Acta 2001, 1531, 169).
The main fatty acids (R and R') are 16:0, 18:0 and 18:2
N-ethoxycarbonyl phosphatidylethanolamine
Another unusual PE derivative was, as the previous one, isolated from Absidia
corymbifera, N-ethoxycarbonyl phosphatidylethanolamine and formed about 9% of total membrane lipids
(Batrakov
SG et al., Biochim Biophys Acta 2001, 1531, 169).
The fatty acid pattern is similar to N-acetyl PE but also with a
prominent proportion of 18:3.
N-acyl
phosphatidylethanolamine
This complex lipid containing three fatty acid chains was isolated in 1965 by Bomstein
(Biochem Biophys Res Comm 1965, 21, 49) from wheat flour. Later, it was shown to be
present in quite all grains (pea seeds, oats and soya beans) but its presence
was also reported in microorganisms, fish, and in mammalian tissues (Schmid
HHO et al., Prog Lipid Res 1990, 29, 1). In oat lipids the major N-acylated
fatty acids are 16:0, 18:2 and 18:1 (Holmbäck
J et al., Lipids 2001, 36, 153-165). In animal cells (heart,
brain, liver and skeletal muscle), the N-acyl chain is frequently palmitic or stearic
acid. The mechanism proposed for the synthesis of this complex phospholipid includes the
action of an N-acyl transferase catalyzing an exchange reaction between the sn-1 position
of phospholipids (probably phosphatidylcholine) and the primary amine of
phosphatidylethanolamine.

Recent reports indicate the importance of N-acyl phosphatidylethanolamine as precursors for N-acylethanolamines, which in turn play a physiological role during germination of seeds (Chapman KD et al., Plant Physiol 1999, 120, 1157) and in defense systems in plants (Tripathy S et al., Plant Physiol 1999, 121, 1299).
N-Acylated ethanolamines were first isolated
from preparations of egg yolk, peanut oils, and soybeans due to their
anti-inflammatory and anti-allergienic properties (Kuehl FA et al., J Am Chem
Soc 1957, 79, 5577). Interestingly, a unique N-acyl phosphatidylethanolamine
was proposed in the brain as a source of N-arachidonoyl ethanolamine (named also anandamide,
from the Sanskrit "ananda" that means bliss), this metabolite appears to be
formed (with a molecule of phosphatidic acid) by phospholipase D action. Further
investigations provide evidence for a multistep pathway by the sequential
actions of hydrolases and glycerophosphodiesterase (Simon
GM et al., J Biol Chem 2008, 283, 9341).

This component (known as endocannabinoid) behaves like an endogenous cannabinoid (Devane et al., Science 1992, 258, 1946) and is now considered as the main ligand of the cannabinoid receptor discovered in 1988 in the rat brain (Devane WA et al., Mol Pharmacol 1988, 34, 605) and thereafter in various types of cells. Intense research are made at present in this field (Review in: Hillard CJ et al., J Lipid Res 1997, 38, 2383; Bezuglov VV et al., Biochemistry, Moscow 1998, 63, 22). Two new ethanolamides were isolated from porcine brain and shown to be ligands of the cannabinoid receptors CB1: dihomo-g-linolenoylethanolamine and docosatetraenoylethanolamine (Hanus L et al., J Med Chem 1993, 36, 3032; Pertwee R et al., Eur J Pharmacol 1994, 259, 115). It is also possible that a palmitoylethanolamine exists in brain tissue. It has been clearly determined that endocannabinoids are involved in the regulation of food intake and body energy reserves and they participate to pathological mechanisms leading to various metabolic dysfunctions. A review on the biological activities, pharmacology, and signal transduction mechanisms for the cannabinoid receptors has been released (Howlett AC, Prost Lipid Med 2002, 68-69, 619). Furthermore, all N-acylethanolamines activate PPAR-a (Sun Y et al., Biochem Soc Trans 2006, 34, 1095). Short-term feeding experiments have shown that the levels of N-acylethanolamines could be affected (Artmann A et al., Biochim Biophys Acta 2008, 1781, 200).
Details on the pharmacology of these compounds are found on Pharmacology Central.
A recent review on bioactive amides of fatty acids is found on the site of Biochimica (Moskov) and in a
review article (Di Marzo V et al.,
Lipids 1999, suppl 34, S319). An extensive review of the
endocannabinoid system, with its targets, main compounds and therapeutic
applications, may be consulted (Lambert DM et al., J Med Chem 2005, 48, 5059).
A review on the determination and
quantitation of fatty acid amides was released by Walker JM et al. (Prost
Lipid Med 2005, 77, 35).
A comprehensive review on the occurrence,
metabolism and functions of this bioactive class of lipid mediators in plant was
written by Chapman KD (Prog
Lipid Res 2004, 43, 302) and an
overview of the biochemistry and pharmacology of anandamide has been released (Hansen
HS et al., Eur J Lipid Sci Technol 2006, 108, 877).
A comprehensive graphical description of the metabolism and the signaling
process of anandamide may be found on the BioCarta
web site.
O-Arachidonoyl ethanolamine with an ester instead of an amide linkage
was isolated from brain (see virodhamine.
Arachidonoyl ethanolamine derivatives
Evidence was accumulated in 1997 that cyclooxygenase (COX-2)
recognizes anandamide and catalyzes its conversion to a new compound,
prostaglandin E2
ethanolamide, belonging to a new class of prostaglandins,
prostaglandin ethanolamines or prostamides
(Yu
M et al., J Biol Chem 1997,
272, 21181). Similarly, it has been shown
that in plants N-linoleyl ethanolamide can be converted by a 13-lipoxygenase
into the corresponding lipoxin (Shrestha
R et al., Plant Physiol 2002, 130, 391).